National Bank of Canada
AMGN icon

National Bank of Canada’s Amgen AMGN Stock Holding History

National Bank of Canada’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,365
Closed -$35.6M – 2835
2024
Q4 		$35.6M Buy
+1,365
New +$405K 0.04% 395

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

National Bank of Canada's AMGN Position: Q2 2026 in Review

National Bank of Canada increased its Amgen (AMGN) stake by 2.2% in Q2 2026, buying an estimated $3.16M and bringing the position to 430,230 shares worth $156M. The position accounts for 0.11% of the portfolio, ranked #154.

National Bank of Canada first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $346M in Q3 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • National Bank of Canada held 430,230 shares of Amgen worth $156M as of Q2 2026.
  • National Bank of Canada bought 9,237 Amgen shares in Q2 2026, an estimated $3.16M.
  • Amgen made up 0.11% of National Bank of Canada's portfolio in Q2 2026, its #154 holding.
  • National Bank of Canada first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Amgen position peaked at $346M in Q3 2025.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.